University of Vermont

College of Medicine

Department of Surgery

Bio for Jason Yeh, M.D.
Jason Yeh, M.D.

Jason Yeh, M.D.

Assistant Professor
Division of Ophthalmology
Department of Surgery


Contact Information
E-mail: Jason.Yeh@uvm.edu
Office Location:
Surgery- Opthamology, FAHC- Mailstop 358WP5, VT

Education

M.D., David Geffen School of Medicine at UCLA, Los Angeles, CA (2003)
Residency in Ophthalmology, University of Chicago Hospitals, Chicago, IL (2004-2007)
Fellowship in Glaucoma, Doheny Eye Institute, University of Southern California, Los Angeles, CA (2007-2008)

Research Interests


Outcome analysis of the treatment of neovascular glaucoma with intravitreal bevacizumab and mitomycin C-assisted trabeculectomy versus aqueous tube shunt.

Academic Appointments

Assistant Professor, Division of Ophthalmology, Department of Surgery, College of Medicine, University of Vermont, Burlington, VT 2009 - present

Publications

Francis BA, Minckler D, Dustin L, Kawji S, Yeh J, Sit A, Mosaed S, Johnstone M, Trabectome Study Group. Combined cataract extraction and trabeculotomy by the itnernal approach for coexisting cataract and open-angle glaucoma: initial results. J Cataract Refract Surg, 2008;34(7):1096-103.

Yeh J, Kravitz D, Francis BA. Rational use of fixed combination of Dorzolamide/Timolol in the management of raised intraocular pressure and glaucoma. Clin Ophthalmol 2008;2(2):389-99.

Lee TL, Yeh J, Friedman J, Yan B, Tang X, Yeh NT, Van Wes C, Chen Z. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Int J Cancer  2008;122(9):1987-98.

Yu M, Yeh J, Van Waes C. Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear facotr-kappaB activation by serum factor(s) in head and neck squamous cells. Cancer Res  2006;66(13):6722-31.

Lee TL, Yeh J, Van Waes C, Chen Z. Epigenetic modification of SOCCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signalling through KAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther  2006;5(1):8-19.